Clinical utility of C3d binding donor-specific anti-human leukocyte antigen antibody detection by single antigen beads after kidney transplantation-a retrospective study.

about

Clinical utility of C3d binding donor-specific anti-human leukocyte antigen antibody detection by single antigen beads after kidney transplantation-a retrospective study.

Item

http://www.wikidata.org/entity/Q48371099

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical utility of C3d bindin ...... ntation-a retrospective study.

@en

Clinical utility of C3d bindin ...... ntation-a retrospective study.

@nl

type

Item

label

Clinical utility of C3d bindin ...... ntation-a retrospective study.

@en

Clinical utility of C3d bindin ...... ntation-a retrospective study.

@nl

prefLabel

Clinical utility of C3d bindin ...... ntation-a retrospective study.

@en

Clinical utility of C3d bindin ...... ntation-a retrospective study.

@nl

P1476

Clinical utility of C3d bindin ...... antation-a retrospective study

@en

P2093

Amer Rajab

http://www.w3.org/2001/XMLSchema#string

Ivan Balazs

http://www.w3.org/2001/XMLSchema#string

Mitchell L Henry

http://www.w3.org/2001/XMLSchema#string

Nicholas R DiPaola

http://www.w3.org/2001/XMLSchema#string

Pat Adams

http://www.w3.org/2001/XMLSchema#string

P2860

Complement is activated by IgG hexamers assembled at the cell surface.

Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.

Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients

A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

The role of complement in antibody-mediated rejection in kidney transplantation.

Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?

Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy.

Flow cytometry based detection of HLA alloantibody mediated classical complement activation.

Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

P304

424-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRI.13106

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ronald P Pelletier

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29265514

http://www.w3.org/2001/XMLSchema#string